WEED.TO - Canopy Growth Corporation
| Previous Close | 56.36 |
| Open | 56.44 |
| Bid | 56.51 x 0 |
| Ask | 56.53 x 0 |
| Day's Range | 56.06 - 57.50 |
| 52 Week Range | 31.81 - 76.68 |
| Volume | 1,210,422 |
| Avg. Volume | 2,198,776 |
| Market Cap | 19.471B |
| Beta (3Y Monthly) | 5.28 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.79 |
| Earnings Date | Jun 21, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 76.00 |
- Yahoo Finance Canada•3 hours ago
Martha Stewart distances herself from 'cannabis' ahead of CBD product launch
Martha Stewart commands a massive audience when she cooks, decorates and gardens. But the 77-year-old food and lifestyle guru has been tight-lipped about her personal use of cannabis.
- Baystreet•2 hours ago
Stocks in play: Lifestyle Delivery Systems Inc.
Announced the delivery of its flagship product, CannaStripsTM, to California Herbal Remedies for roll ...
- Market Realist•3 hours ago
Canopy Growth Expands Its Product Offering, Adds Oral Thins
On June 19, Canopy Growth (WEED) (CGC) and CURE Pharmaceutical announced a partnership to create a new CBD-based oral delivery thin film. The oral thins will be available for distribution globally.
- The Motley Fool•5 hours ago
Why Cannabis Stocks Are Among the Best Choices for Young Investors to Buy in Their TFSAs
Learn why young investors should be willing to look past the short-term risks of their investments in favour of their long-term potential and how stocks like Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) might end up looking like unbelievable bargains 40 years from now.
- The Motley Fool•5 hours ago
What Can Investors Expect From Canopy Growth’s (TSX:WEED) Q4 Results Tomorrow?
Canopy Growth Corp (TSX:WEED)(NYSE:CGC) will release its fourth-quarter results tomorrow. Here's what to look out for.
- GlobeNewswire•6 hours ago
CURE Pharmaceutical and Canopy Growth to Produce CBD Oral Thin Films
CURE Pharmaceutical (CURR), an innovative drug delivery and development company, today announced it is collaborating with Canopy Growth Corporation (WEED.TO) (CGC), (“Canopy”) to develop a new low-dose cannabidiol (CBD) oral thin film (OTF) using CURE’s patented CUREfilm™ technology for global distribution. “This collaboration builds on our licensing agreement with Canopy and accelerates product commercialization,” said Rob Davidson, CEO of CURE Pharmaceutical. CURE is registered with the U.S. Drug Enforcement Agency (DEA) to develop and manufacture cannabis-derived and synthetic cannabinoid-based products using its CUREfilm technology at its facility in Oxnard, Calif. With CUREfilm, the delivery of cannabinoids is easier and more effective as it offers increased bioavailability, ease and precision of dosing and greater palatability.
- Motley Fool•7 hours ago
Profit Projections Are Still Plunging for the 3 Most Popular Pot Stocks
Marijuana may not have investors seeing much green through 2020.
- Barrons.com•7 hours ago
Marijuana Company Canopy Growth Group Reports Earnings Tomorrow. Here’s What to Expect.
Canadian cannabis company Canopy Growth is scheduled to report fiscal fourth-quarter 2019 earnings on Thursday after the market closes.
- Market Realist•yesterday
Canopy Updates on Europe, Australia, and Africa
Canopy Growth is making progress in the Australian market through its Spectrum Therapeutics brand, which caters to the demand for medical cannabis products. According to the company, the number of medical patients in the country has increased ten times in the last year.
- Market Realist•yesterday
What Would Legalization in New York State Mean for Cannabis?
New York has been on the fence about legalizing marijuana. In a series of tweets, New York City Mayor Bill De Blasio expressed strong support for legalizing cannabis the “RIGHT way.”
- Market Realist•yesterday
Canopy Growth Pens an Agreement with Procaps—Here Are the Details
On June 18, Canopy Growth (WEED) (CGC) announced another international development: it has entered into an agreement with Procaps in Colombia. According to Canopy Growth, Procaps is active across the world, exporting its products to over 50 international markets.
- Motley Fool•yesterday
Here's What's Behind June's Big Marijuana Stock Winner
Look beyond the obvious picks to find an impressive performance.
- Market Realist•yesterday
Canopy Growth’s 4Q Earnings: Profitability Expectations
On June 20, Canopy Growth (WEED) (CGC) is expected to report sales of 91.1 million Canadian dollars and a gross income of 24.4 million Canadian dollars. The company's margins are expected to compress.
- The Motley Fool•yesterday
Canopy Growth (TSX:WEED) Sets Profit Goal for Its Canadian Operations
As it shifts its focus to the U.S. market, Canopy Growth Corp (TSX:WEED)(NYSE:CGC) is going to need to run a much tighter ship in Canada.
- Market Realist•yesterday
Canopy Growth’s 4Q Earnings: What Can Investors Expect?
On June 20, Canopy Growth (WEED) (CGC) is scheduled to announce its fourth-quarter and fiscal 2019 earnings after the market closes. The company's guidance will likely set the tone for the cannabis industry's near-term expectations.
- The Motley Fool•2 days ago
Is it Too Late to Invest in Marijuana Stocks?
Although marijuana stocks like Canopy Growth Corp (TSX:WEED)(NYSE:CGC) have been rising for a long time, it may not be too late to earn some gains from them.
- Market Realist•2 days ago
Cannabis Sector Sentiment Weakened Last Week
The sentiment towards the cannabis sector weakened further last week, as major industry players ended in the negative territory. HEXO (HEXO), which released disappointing earnings on June 12, was one of the key reasons for the extension of the weakness in the sector last week.
- Motley Fool•3 days ago
The 5 Most Profitable Pot Stocks on the Planet
Most cannabis companies are losing money. These aren't.
- Motley Fool•3 days ago
Better Buy: Canopy Growth vs. Scotts Miracle-Gro
Which stock wins in a battle between the biggest cannabis producer by market cap and the biggest supplier to the cannabis industry?
- The Motley Fool•3 days ago
The U.S. Cannabis Market Will Send Canopy Growth (TSX:WEED) Stock Into the Stratosphere
Canopy Growth Corp (TSX:WEED)(NYSE:CGC) is the top Canadian pot company to watch as the United States creeps closer to broader legalization.
- Motley Fool•3 days ago
4 of the 14 Most Widely Held Stocks on Investing App Robinhood Are Marijuana Stocks
Millennials love cannabis stocks. Unfortunately, two of their favorites could be duds.
- Motley Fool•4 days ago
The Best Cannabis Stock to Buy in June
This industry leader can help you earn a marijuana-fueled fortune.
CNW Group•5 days agoCanopy Growth and Acreage Holdings Remind Shareholders to Vote FOR Canopy Growth's Plan to Acquire Acreage
Canopy Growth's brands, technology and know-how is anticipated to provide Acreage with a significant advantage in an increasingly competitive U.S. market and fuel Acreage's growth. Acreage shareholders will benefit from Acreage's ability to achieve its growth strategy with an anticipated reduced cost of capital based on Canopy Growth affiliation. Canopy Growth shareholders will benefit from accelerated and turnkey access to the U.S. cannabis market upon the closing of the Transaction.
- Yahoo Finance•7 days ago
CBD leader CV Sciences jumps 10% on Kroger deal to sell CBD oil in 17 US states
Shares of CBD company CV Sciences jumped 10% on a deal with retailer Kroger to sell its oils in nearly 1,000 stores.
- The Motley Fool•7 days ago
4 Things to Watch as Canopy Growth (TSX:WEED) Reports Earnings Next Week
Here's what I would be focused on as marijuana king Canopy Growth Corp (TSX:WEED)(NYSE:CGC) reports earnings next week.
